Companies in the Medtech business provides medical device products within the medtech market and assistive equipment within home healthcare.
|3 months ending||12 months ending|
For the quarter, Medtech’s net sales increased by 38 percent to SEK 611m (442), including organic growth of 2 percent and acquired growth of 41 percent, while exchange rate fluctuations had a negative effect of 5 percent. Net sales related to COVID-19 accounted for SEK 80m and organic growth, excluding COVID-19 decreased with 4 percent. EBITA rose 77 percent to SEK 64m (37) and EBITA margin amounted to 10.6 percent (8.3).
Dynamisk graf: Net sales (SEKm)
Dynamisk graf: EBITA (SEKm)
Medtech’s businesses had relatively stable overall sales of medical devices in the quarter, but with large differences between different product segments. Sales of personal protective equipment to Nordic customers have normalised as hospitals largely have inventory to meet their own needs. In Central Europe, however, we have had large one-off sales of protective equipment. Elective surgery activity has been low in the quarter in all markets. According to official statistics in Sweden, about 50% fewer operations than normal were performed this quarter, and in Central and Eastern Europe cardiac surgery has decreased by between 25-50%, depending on the procedure. In the first quarter, the challenges for our homecare companies increased again due to reduced opportunities for testing and installations of various assistive devices. Overall, sales were stable as activity increased in March thanks to vaccinations of the elderly population.